_id
6915e873bc934aba376b1b72
Ticker
PSYBF
Name
PsyBio Therapeutics Corp
Exchange
PINK
Address
1624 Washington Street, Denver, CO, United States, 80203
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.psybiolife.com
Description
PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company was incorporated in 2009 and is headquartered in Denver, Colorado.
Last Close
-
Volume
-
Current Price
0
Change
0
Last Updated
2026-01-06T09:40:08.623Z
Image
-
Ipo Date
-
Market Cap
1275
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-06-30
Revenue
0
Cost Of Revenue
25000
Gross Profit
-25000
Operating Expenses
131992
Operating Income
-157000
Interest Expense
0
Pretax Income
-182000
Net Income
-182000
Eps
-0.0014199226064161778
Dividends Per Share
-
Shares Outstanding
80851793
Income Tax Expense
-19.01
EBITDA
-162990
Operating Margin
-
Total Other Income Expense Net
-25000
Cash
12373
Short Term Investments
0
Receivables
-
Inventories
-
Total Current Assets
105852
Property Plant Equipment
88714
Total Assets
283143
Payables
1385992
Short Term Debt
96139
Long Term Debt
-
Total Liabilities
1970670
Equity
-1687527
Bs_currency_symbol
USD
Depreciation
0
Change In Working Capital
-210510
Cash From Operations
339600
Capital Expenditures
0.94
Cash From Investing
622
Cash From Financing
558708
Net Change In Cash
-49150
Cf_currency_symbol
USD
PE
-
PB
-
ROE
10.785012624983185
ROA
-64.27847412791417
FCF
339599.06
Fcf Percent
-
Piotroski FScore
2
Health Score
37
Deep Value Investing Score
4
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
6.3
Garp Investing Score
2.5
Growth Investing Score
2
Momentum Investing Score
2
Net Net Investing Score
3.5
Quality Investing Score
3
Value Investing Score
2
Quarters > 0 > quarter
2023-06-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
25000
Quarters > 0 > income Statement > gross Profit
-25000
Quarters > 0 > income Statement > operating Expenses
131992
Quarters > 0 > income Statement > operating Income
-157000
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
-182000
Quarters > 0 > income Statement > net Income
-182000
Quarters > 0 > income Statement > eps
-0.0014199226064161778
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
128176000
Quarters > 0 > income Statement > income Tax Expense
-19.01
Quarters > 0 > income Statement > EBITDA
-162990
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-25000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
12373
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
105852
Quarters > 0 > balance Sheet > property Plant Equipment
88714
Quarters > 0 > balance Sheet > total Assets
283143
Quarters > 0 > balance Sheet > payables
1385992
Quarters > 0 > balance Sheet > short Term Debt
96139
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1970670
Quarters > 0 > balance Sheet > equity
-1687527
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-144688
Quarters > 0 > cash Flow > depreciation
0
Quarters > 0 > cash Flow > change In Working Capital
-210510
Quarters > 0 > cash Flow > cash From Operations
339600
Quarters > 0 > cash Flow > capital Expenditures
0.94
Quarters > 0 > cash Flow > cash From Investing
622
Quarters > 0 > cash Flow > cash From Financing
558708
Quarters > 0 > cash Flow > net Change In Cash
-49150
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.0014199226064161778
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
10.785012624983185
Quarters > 0 > ratios > ROA
-64.27847412791417
Quarters > 0 > ratios > FCF
339599.06
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
37
Quarters > 1 > quarter
2023-03-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
12500
Quarters > 1 > income Statement > gross Profit
-12500
Quarters > 1 > income Statement > operating Expenses
763513
Quarters > 1 > income Statement > operating Income
-714208
Quarters > 1 > income Statement > interest Expense
3392
Quarters > 1 > income Statement > pretax Income
-811552
Quarters > 1 > income Statement > net Income
-811491
Quarters > 1 > income Statement > eps
-0.006331045102600268
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
128176468
Quarters > 1 > income Statement > income Tax Expense
3392
Quarters > 1 > income Statement > EBITDA
-770079
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-9956
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
69017
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
201425
Quarters > 1 > balance Sheet > property Plant Equipment
88714
Quarters > 1 > balance Sheet > total Assets
299826
Quarters > 1 > balance Sheet > payables
410207
Quarters > 1 > balance Sheet > short Term Debt
96140
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1957048
Quarters > 1 > balance Sheet > equity
-1657222
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-811491
Quarters > 1 > cash Flow > depreciation
38020
Quarters > 1 > cash Flow > change In Working Capital
194623
Quarters > 1 > cash Flow > cash From Operations
-355487
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
622
Quarters > 1 > cash Flow > cash From Financing
290829
Quarters > 1 > cash Flow > net Change In Cash
-65328
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.006331045102600268
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
48.96694588896358
Quarters > 1 > ratios > ROA
-270.6539793079986
Quarters > 1 > ratios > FCF
-355487
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2022-12-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
38076
Quarters > 2 > income Statement > gross Profit
-38076
Quarters > 2 > income Statement > operating Expenses
896952
Quarters > 2 > income Statement > operating Income
-947156
Quarters > 2 > income Statement > interest Expense
4432
Quarters > 2 > income Statement > pretax Income
-941644
Quarters > 2 > income Statement > net Income
-941644
Quarters > 2 > income Statement > eps
-0.015018070043933936
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
62700733
Quarters > 2 > income Statement > income Tax Expense
4433
Quarters > 2 > income Statement > EBITDA
-899193
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-6616
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
848
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
253322
Quarters > 2 > balance Sheet > property Plant Equipment
126734
Quarters > 2 > balance Sheet > total Assets
390366
Quarters > 2 > balance Sheet > payables
456994
Quarters > 2 > balance Sheet > short Term Debt
135487
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1981308
Quarters > 2 > balance Sheet > equity
-1590942
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-941644
Quarters > 2 > cash Flow > depreciation
38019
Quarters > 2 > cash Flow > change In Working Capital
730935
Quarters > 2 > cash Flow > cash From Operations
-165981
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
48992
Quarters > 2 > cash Flow > cash From Financing
142712
Quarters > 2 > cash Flow > net Change In Cash
-23383
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.015018070043933936
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
59.18782708609114
Quarters > 2 > ratios > ROA
-241.22080304124847
Quarters > 2 > ratios > FCF
-165981
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
43
Quarters > 3 > quarter
2022-09-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
12500
Quarters > 3 > income Statement > gross Profit
-12500
Quarters > 3 > income Statement > operating Expenses
813098
Quarters > 3 > income Statement > operating Income
-922483
Quarters > 3 > income Statement > interest Expense
5429
Quarters > 3 > income Statement > pretax Income
-921899
Quarters > 3 > income Statement > net Income
-921899
Quarters > 3 > income Statement > eps
-0.00828010760505042
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
111339012
Quarters > 3 > income Statement > income Tax Expense
7951
Quarters > 3 > income Statement > EBITDA
-878449
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
584
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
180641
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
331011
Quarters > 3 > balance Sheet > property Plant Equipment
164753
Quarters > 3 > balance Sheet > total Assets
506696
Quarters > 3 > balance Sheet > payables
109093
Quarters > 3 > balance Sheet > short Term Debt
158034
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1314567
Quarters > 3 > balance Sheet > equity
-807871
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-921899
Quarters > 3 > cash Flow > depreciation
38021
Quarters > 3 > cash Flow > change In Working Capital
90184
Quarters > 3 > cash Flow > cash From Operations
-707898
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
856736
Quarters > 3 > cash Flow > cash From Financing
-27396
Quarters > 3 > cash Flow > net Change In Cash
121956
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.00828010760505042
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
114.11462968716539
Quarters > 3 > ratios > ROA
-181.94321644536367
Quarters > 3 > ratios > FCF
-707898
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
43
Annuals > 0 > quarter
2022-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
50000
Annuals > 0 > income Statement > gross Profit
-50000
Annuals > 0 > income Statement > operating Expenses
4287711
Annuals > 0 > income Statement > operating Income
-4337711
Annuals > 0 > income Statement > interest Expense
21052
Annuals > 0 > income Statement > pretax Income
-4886000
Annuals > 0 > income Statement > net Income
-4886000
Annuals > 0 > income Statement > eps
-0.04369913245684644
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
111810000
Annuals > 0 > income Statement > income Tax Expense
49164
Annuals > 0 > income Statement > EBITDA
-4526000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-548352
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
848
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
253322
Annuals > 0 > balance Sheet > property Plant Equipment
126734
Annuals > 0 > balance Sheet > total Assets
390366
Annuals > 0 > balance Sheet > payables
906994
Annuals > 0 > balance Sheet > short Term Debt
270912
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1981308
Annuals > 0 > balance Sheet > equity
-1590942
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-4886063
Annuals > 0 > cash Flow > depreciation
152080
Annuals > 0 > cash Flow > change In Working Capital
610912
Annuals > 0 > cash Flow > cash From Operations
-3437030
Annuals > 0 > cash Flow > capital Expenditures
0.37
Annuals > 0 > cash Flow > cash From Investing
3524428
Annuals > 0 > cash Flow > cash From Financing
-54977
Annuals > 0 > cash Flow > net Change In Cash
32866
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.04369913245684644
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
307.11364713484215
Annuals > 0 > ratios > ROA
-1251.6458912917622
Annuals > 0 > ratios > FCF
-3437030.37
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2021-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
62500
Annuals > 1 > income Statement > gross Profit
-62500
Annuals > 1 > income Statement > operating Expenses
9605866
Annuals > 1 > income Statement > operating Income
-8228208
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-11018878
Annuals > 1 > income Statement > net Income
-11018878
Annuals > 1 > income Statement > eps
-0.10304276429606771
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
106935000
Annuals > 1 > income Statement > income Tax Expense
1431115
Annuals > 1 > income Statement > EBITDA
-8228208
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-1350512
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
124392
Annuals > 1 > balance Sheet > short Term Investments
3680714
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
3995414
Annuals > 1 > balance Sheet > property Plant Equipment
0
Annuals > 1 > balance Sheet > total Assets
4008204
Annuals > 1 > balance Sheet > payables
440538
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1290538
Annuals > 1 > balance Sheet > equity
2717666
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-11018878
Annuals > 1 > cash Flow > depreciation
0
Annuals > 1 > cash Flow > change In Working Capital
667920
Annuals > 1 > cash Flow > cash From Operations
-6949776
Annuals > 1 > cash Flow > capital Expenditures
3739
Annuals > 1 > cash Flow > cash From Investing
-3564046
Annuals > 1 > cash Flow > cash From Financing
10368019
Annuals > 1 > cash Flow > net Change In Cash
-145308
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.10304276429606771
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
-405.45372389395897
Annuals > 1 > ratios > ROA
-274.908113459295
Annuals > 1 > ratios > FCF
-6953515
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2020-12-31
Annuals > 2 > income Statement > revenue
-
Annuals > 2 > income Statement > cost Of Revenue
1535000
Annuals > 2 > income Statement > gross Profit
-1535000
Annuals > 2 > income Statement > operating Expenses
4901000
Annuals > 2 > income Statement > operating Income
-6436000
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-6436000
Annuals > 2 > income Statement > net Income
-6436000
Annuals > 2 > income Statement > eps
-0.20370956510729885
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
31594000
Annuals > 2 > income Statement > income Tax Expense
0.35
Annuals > 2 > income Statement > EBITDA
353
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
353
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
269700
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
286496
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
286496
Annuals > 2 > balance Sheet > payables
418674
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1023409
Annuals > 2 > balance Sheet > equity
-736913
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-6435657
Annuals > 2 > cash Flow > depreciation
6436000
Annuals > 2 > cash Flow > change In Working Capital
527132
Annuals > 2 > cash Flow > cash From Operations
-863760
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-3564046
Annuals > 2 > cash Flow > cash From Financing
1157978
Annuals > 2 > cash Flow > net Change In Cash
294218
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.20370956510729885
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
873.3731118870206
Annuals > 2 > ratios > ROA
-2246.453702669496
Annuals > 2 > ratios > FCF
-863760
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
43
Annuals > 3 > quarter
2019-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
38969
Annuals > 3 > income Statement > operating Income
-38972
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-16158
Annuals > 3 > income Statement > net Income
-16158
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
-172000
Annuals > 3 > income Statement > EBITDA
155703
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
22814
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
161562
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
161562
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
161562
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
33570
Annuals > 3 > balance Sheet > equity
127991
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-16158
Annuals > 3 > cash Flow > depreciation
171860
Annuals > 3 > cash Flow > change In Working Capital
-30785
Annuals > 3 > cash Flow > cash From Operations
-24133
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
-31985
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-12.62432514786196
Annuals > 3 > ratios > ROA
-10.001114123370595
Annuals > 3 > ratios > FCF
-24133
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
44
Valuation > metrics > PE
-0.0014199226064161778
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
10.785012624983185
Profitability > metrics > ROA
-171.93817783320105
Profitability > final Score
37
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-8.25881115202525
Risk > final Score
-3
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.07141878821777563
Liquidity > metrics > Quick Ratio
0.07141878821777563
Liquidity > final Score
14
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
55
Prev Profitabilities > 2
55
Prev Risks > 0
-812
Prev Risks > 1
-825
Prev Risks > 2
-650
Prev Liquidities > 0
30
Prev Liquidities > 1
31
Prev Liquidities > 2
81
Updated At
2026-01-20T22:26:10.820Z
Earnings History > 0 > period
2023-06-30
Earnings History > 0 > report Date
2023-08-30
Earnings History > 0 > date
2023-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
CAD
Earnings History > 0 > eps Actual
-0.0014
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2023-03-31
Earnings History > 1 > report Date
2023-05-31
Earnings History > 1 > date
2023-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
CAD
Earnings History > 1 > eps Actual
-0.0063
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2022-12-31
Earnings History > 2 > report Date
2023-03-01
Earnings History > 2 > date
2022-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
CAD
Earnings History > 2 > eps Actual
-0.015
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-09-30
Earnings History > 3 > report Date
2022-11-30
Earnings History > 3 > date
2022-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
CAD
Earnings History > 3 > eps Actual
-0.0083
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-08-29
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
CAD
Earnings History > 4 > eps Actual
-0.01
Earnings History > 4 > eps Estimate
-0.02
Earnings History > 4 > eps Difference
0.01
Earnings History > 4 > surprise Percent
50
Earnings History > 5 > period
2022-03-31
Earnings History > 5 > report Date
2022-05-30
Earnings History > 5 > date
2022-03-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
CAD
Earnings History > 5 > eps Actual
-0.01
Earnings History > 5 > eps Estimate
-0.02
Earnings History > 5 > eps Difference
0.01
Earnings History > 5 > surprise Percent
50
Earnings History > 6 > period
2021-12-31
Earnings History > 6 > report Date
2022-03-02
Earnings History > 6 > date
2021-12-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
-0.03
Earnings History > 6 > eps Estimate
-0.02
Earnings History > 6 > eps Difference
-0.01
Earnings History > 6 > surprise Percent
-50
Earnings History > 7 > period
2021-09-30
Earnings History > 7 > report Date
2021-11-29
Earnings History > 7 > date
2021-09-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
-0.03
Earnings History > 7 > eps Estimate
-0.01
Earnings History > 7 > eps Difference
-0.02
Earnings History > 7 > surprise Percent
-200
Earnings History > 8 > period
2021-06-30
Earnings History > 8 > report Date
2021-08-30
Earnings History > 8 > date
2021-06-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.04
Earnings History > 8 > eps Estimate
-0.01
Earnings History > 8 > eps Difference
-0.03
Earnings History > 8 > surprise Percent
-300
Earnings History > 9 > period
2021-03-31
Earnings History > 9 > report Date
2021-06-01
Earnings History > 9 > date
2021-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.0294
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-12-31
Earnings History > 10 > report Date
2021-03-31
Earnings History > 10 > date
2020-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
CAD
Earnings History > 10 > eps Actual
-0.0296
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0296
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-12-31
Earnings History > 11 > report Date
2020-03-31
Earnings History > 11 > date
2019-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CAD
Earnings History > 11 > eps Actual
-0.0001
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.0001
Earnings History > 11 > surprise Percent
-
PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company was incorporated in 2009 and is headquartered in Denver, Colorado.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2023-06-30)
Health Score
Return on Equity (ROE)
-
Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of PsyBio Therapeutics Corp
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2023-06-30
EPS Actual
-0.0014
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2023-06-30)
(Last Updated 2023-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.